Novartis innovative therapy can help high-risk patients control bad cholesterol

GRACE, a pseudonym used to protect her identity, is eagerly awaiting the birth of her granddaughter. However, the retiree in her early 60s and successful entrepreneur from Alabang is battling hypertension, diabetes, and high LDL-C ("bad cholesterol"). These comorbidities threaten to rob her of the chance to witness her granddaughter grow up and achieve milestones in life.

High LDL-C levels resulted in the accumulation of fatty plaque deposits in the arteries of Grace's heart. Because of her severely blocked coronary arteries, Grace suffered two heart attacks, the first in 2017 followed by another in 2018. Despite multiple open-heart surgeries and statin therapy to control cholesterol, Grace lives in constant fear that her health could take a turn for the worse at any moment.